The novel HLA‐B*44:03:67 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual
HLA · 2023
DOI: 10.1111/tan.15118 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Ke-Ming Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China. Hauptthemen laut MEDLINE: HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*44:03:67 differs from HLA‐B*44:03:02:01 by one nucleotide in exon 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
ORCID-Profile: Zhi-Yang Yuan, Lin An
Zitieren
APA
Du, K. M., Ma, L., Yuan, Z. Y., An, L., & Zheng, Z. Z. (2023). The novel HLA‐B*44:03:67 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. https://doi.org/10.1111/tan.15118
Vancouver
Du KM, Ma L, Yuan ZY, An L, Zheng ZZ. The novel HLA‐B*44:03:67 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. 2023. doi:10.1111/tan.15118
BibTeX
@article{Du2023,
author = {Du, Ke-Ming and Ma, Li and Yuan, Zhi-Yang and An, Lin and Zheng, Zhong-Zheng},
title = {The novel HLA‐B*44:03:67 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15118}
}
EUVIMED